Related Experiment Videos
High density lipoprotein cholesterol and arteriography in intermittent claudication
J Hørby1, P Grande, A Vestergaard
1Department of Vascular Surgery and Urology, Gentofte Hospital, University of Copenhagen, Hellerup.
European Journal of Vascular Surgery
|August 1, 1989
Summary
Patients with peripheral arterial disease (PAD) have lower high-density lipoprotein cholesterol (HDL-C) and higher low-density lipoprotein cholesterol (LDL-C) levels. HDL-C levels correlate negatively with the severity of arteriosclerotic lesions in PAD patients.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
- Vascular Biology
Background:
- Peripheral arterial disease (PAD) is characterized by intermittent claudication.
- Lipoprotein and lipid profiles are crucial indicators of cardiovascular health.
- Understanding lipid abnormalities in PAD is essential for risk stratification and management.
Purpose of the Study:
- To compare plasma lipoprotein and lipid concentrations between PAD patients and matched controls.
- To investigate the relationship between lipid profiles and the extent of arteriosclerotic lesions in PAD.
Main Methods:
- Plasma lipid and lipoprotein levels (HDL-C, LDL-C, VLDL, total cholesterol, triglycerides) were measured in 76 PAD patients and 21 controls.
- Controls were matched for age, sex, BMI, alcohol, and tobacco consumption.
- Arteriograms were evaluated to assess the extent of arteriosclerotic lesions.
Main Results:
- PAD patients exhibited significantly lower HDL-C (P<0.01) and higher LDL-C (P<0.05) compared to controls.
- Lower HDL-C/LDL-C and HDL-C/total cholesterol ratios were observed in the PAD group (P<0.005).
- A significant negative correlation was found between HDL-C concentrations and the severity of lower extremity arteriosclerotic lesions (P<0.05).
Conclusions:
- Lipoprotein profiles, specifically lower HDL-C and higher LDL-C, are altered in patients with PAD.
- HDL-C levels are inversely associated with the extent of vascular disease severity in PAD.
- These findings highlight the role of lipid dysregulation in the pathophysiology and progression of PAD.